ROL — Rollins, Inc.

The market turned negative after Q2 2026 adjusted EPS of $0.32 missed consensus and management lowered its organic growth outlook, citing residential pest-control softness. Sell-side targets were slashed across the board, the consensus rating has shifted to Hold, and price action shows a sharp de-rating from a 5-year average P/E of ~49.7x to ~32.7x TTM earnings.

Revenue is still growing but clearly decelerating: Q2 2026 revenue grew ~7.9% YoY versus ~10.2% in Q1 2026 and ~12.0% in Q3 2025. Net income growth slowed to +1.7% YoY in Q2 2026 after +19.4% in Q3 2025, and diluted EPS went from $0.29 to $0.30. Operating margin compressed to 18.7% in Q2 2026 from 19.8% a year earlier; TTM operating margin is now 18.7% versus the ~20%+ levels seen in 2024. This is a real deceleration, not a one-quarter blip, and management confirmed the softer residential trend by cutting guidance. TTM FCF also ticked down to roughly $619M from about $632M a year earlier, so the earnings slowdown is showing up in cash generation too.

At $35.94, the stock is 'cheap vs. its own history' but not cheap on absolute terms: 32.7x TTM EPS, ~31.5x next-FY consensus EPS of $1.142, PEG ~3.7, P/S ~4.4, and P/B ~12.1. The 5-year average P/E was 49.7x and average P/S was 6.99x, so the premium has mostly been stripped out. Still, with EPS growth likely in the low-to-mid single digits near term, a low-to-mid 30s multiple is roughly fair rather than a bargain.

The current price is pricing in low-single-digit or flat earnings growth and no residential re-acceleration. If Rollins simply stabilizes and delivers ~$1.14 next FY, the stock can hold around $36-38; another guidance cut would put 28-30x forward earnings around $32-34, matching the low end of analyst targets. A re-rating toward $40+ would require Q3 evidence that residential demand is stabilizing and operating margins are recovering toward 20%.

As of 2026-08-27, RSI was 33.29, near oversold but not completely washed out. Price was 2.5% below the 20-day SMA, 11.3% below the 50-day SMA, and 32.1% below the 200-day SMA. That is a strong downtrend, and sitting so far below the 200-day means catching a falling knife remains a real risk. An oversold bounce is possible, but there is no confirmed bottom until the stock reclaims its 50-day moving average and RSI holds above 40.

• Elevated Treasury yields have pressured high-multiple defensive 'bond proxy' stocks, forcing a valuation reset across the group.
• Persistent cost-of-living pressure is softening discretionary residential pest-control spending, Rollins' key growth engine.
• The FTC's noncompete order raises employee-retention risk across Rollins' 18,000+ worker base.
• Commercial pest-control demand remains more resilient, providing a partial offset to residential weakness.
• Bolt-on M&A and the company's recurring-revenue business model remain structural positives, though near-term execution is under scrutiny.

• Q3 2026 earnings on October 28, 2026: consensus EPS of $0.35 and any sign that residential demand is stabilizing.
• Evidence that cost-realignment initiatives protect operating margins despite softer organic growth.
• Restoration of full-year organic growth guidance, or an upside surprise in commercial revenue.
• Continued M&A deployment or more visible progress on technician retention and pricing.

• Further residential softness and another guidance cut could push the stock down toward the $32 low-target area.
• Operating margin compression could persist if pricing power fades or labor and input costs rise faster than cost savings.
• The FTC noncompete ban could increase technician and manager turnover, undermining service quality and retention.
• The defensive premium could keep unwinding if rates stay high and growth stays pedestrian.
• Balance-sheet liquidity looks tight on a current-ratio basis (0.63), though FCF remains solid.

Rollins is a high-quality pest-control franchise with strong ROIC, negative accruals, and a stickier-than-average recurring revenue model, but the current operational story is deteriorating: residential growth slowed, guidance was cut, and margins are compressing. After the sharp drawdown, the stock is no longer egregiously priced, but there is no evidence yet of an operational inflection. I would stay neutral and wait for Q3 confirmation or a more compelling entry below the current level.

I applied a justified forward P/E of ~32x—derived from a Gordon-growth framework using roughly 64% payout, ~8% cost of equity, and ~6% sustainable long-term growth consistent with 21% ROIC—to next-FY consensus EPS of $1.142, yielding ~$36.5. This is well below the 5-year average P/E of 49.7x, reflecting the slower current growth trajectory and the recent guidance cut.